Juan-José Lahuerta (Juan Jose Lahuerta, Juan J Lahuerta, J J Lahuerta, Juan José Lahuerta, Juan-Jose Lahuerta)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 32

Top Venues

Blood cancer journal

Cancers

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood

Fundación Pethema

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fundación Pethema Jan 01 1994

Spain

Executive Secretary

Hospital Universitario 12 de Octubre May 01 1976

Spain

Jefe de la sección Clínica :: Hematología

Publications

A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Rafael Rios-Tamayo, Ramón Lecumberri, María Teresa Cibeira, Verónica González-Calle, Rafael Alonso, Amalia Domingo-González, Elena Landete, Cristina Encinas, Belén Iñigo, María-Jesús Blanchard, Elena Alejo, Isabel Krsnik, Manuel Gómez-Bueno, Pablo Garcia-Pavia, Javier Segovia, Laura Rosinol, Juan-José Lahuerta, Joaquin Martinez Lopez, Joan Bladé
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis. Cancers 16 (9) (2024)
Noemi Puig, Cristina Agullo Roca, Teresa Contreras Sanfeliciano, María-Teresa Cedena, Joaquín Martínez-López, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Belén Iñigo Rodríguez, Anna Sureda, Sunil Lakhwani, Javier de la Rubia Comos, Verónica González De La Calle, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, Sergio Castro, Laura Rosinol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Juan José Lahuerta, Maria-Victoria Mateos-Manteca
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma. Blood (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Rafael Rios-Tamayo, Ramón Lecumberri, María Teresa Cibeira, Verónica González-Calle, Rafael Alonso, Amalia Domingo-González, Elena Landete, Cristina Encinas, Belén Iñigo, María-Jesús Blanchard, Elena Alejo, Isabel Krsnik, Manuel Gómez-Bueno, Pablo Garcia-Pavia, Javier Segovia, Laura Rosinol, Juan-José Lahuerta, Joaquin Martinez Lopez, Joan Bladé
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis. Cancers 16 (9) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, María-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco Salvatore Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios-Tamayo, José María M Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosinol, Juan-José Lahuerta, Joan Bladé, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta, null null, null null
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications 14 (1) (2023)
Laura Rosinol, Albert Ortiol, Rafael Rios-Tamayo, María-Jesús Blanchard, Isidro Jarque, Joan Bargay, Miguel-Teodoro T Hernandez Garcia, Valentín Cabañas, Estrella Carrillo-Cruz, Anna Sureda, Joaquin Martinez Lopez, Isabel Krsnik, Maria-Esther Gonzalez, Luis Felipe Casado Montero, Josep-Maria Marti, Cristina Encinas, Felipe de Arriba, Luis Palomera, Maria Antonia Sampol, Yolanda Gonzalez-Montes, Elena Cabezudo, Juan José Lahuerta, Noemi Puig, Maria-Teresa Cedena, Javier de la Cruz, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé
LENALIDOMIDE AND DEXAMETHASONE WITH OR WITHOUT IXAZOMIB MAINTENANCE TAILORED BY RESIDUAL DISEASE STATUS IN MYELOMA. Blood (2023)
Rafael Ríos-Tamayo, Isabel Krsnik, Manuel Gómez-Bueno, Pablo Garcia-Pavia, Javier Segovia-Cubero, Ana Huerta, Clara Salas, Ramona Ángeles Silvestre, Amelia Sánchez, Marta Manso, Laura Delgado, Juan-José Lahuerta, Joaquin Martinez Lopez, Rafael F Duarte
AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor. Life (Basel, Switzerland) 13 (7) (2023)
Rafael Rios-Tamayo, Maria-José Sánchez, Sandra Gómez-Rojas, Miguel Rodríguez Barranco, Gloria Pérez Segura, Daniel Redondo-Sánchez, Gonzalo Carreno-Tarragona, Antonio Rodríguez Nicolás, Francisco Ruiz-Cabello, Pilar Jiménez, Rafael Alonso, Juan-José Lahuerta, Joaquin Martinez Lopez, Rafael F Duarte
Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based Approach. Diagnostics (Basel, Switzerland) 13 (6) (2023)
Rafael Rios-Tamayo, Maria-José Sánchez, Sandra Gómez-Rojas, Miguel Rodríguez Barranco, Gloria Pérez Segura, Daniel Redondo-Sánchez, Gonzalo Carreno-Tarragona, Antonio Rodríguez Nicolás, Francisco Ruiz-Cabello, Pilar Jiménez, Rafael Alonso, Juan-José Lahuerta, Joaquin Martinez Lopez, Rafael F Duarte
Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based Approach. Diagnostics (Basel, Switzerland) 13 (6) (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Verónica González De La Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, María-Teresa Cedena, Juan José Lahuerta, Laura Rosiñol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood advances 6 (11) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Juan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, Iria Vazquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sanchez, Cristina Jiménez, Laura Rosinol, Norma C Gutiérrez, Yanira Ruiz-Heredia, Santiago Barrio, Albert Oriol, Maria-Luisa Martin-Ramos, María-Jesús Blanchard, Rosa María Ayala, Rafael Ríos-Tamayo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Gorka Alkorta-Aranburu, Xabier Agirre, Joan Bladé, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Jesús F San-Miguel, María-José Calasanz, Miriam Santero, Joaquín Martínez-Lopez
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 14 (20) (2022)
Adrián Mosquera Orgueira, Marta Sonia González Pérez, Jose Diaz Arias, Laura Rosinol, Albert Ortiol, Ana Isabel Teruel, Joaquin Martinez Lopez, Luis Palomera, Miquel Granell, Maria Jesus Blanchard, Javier de la Rubia, Ana López de la Guia, Rafael Rios-Tamayo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Enrique Bengoechea, María José Calasanz, Norma Gutierrez, Maria Luis Martin, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, null null
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group. Blood cancer journal 12 (4) (2022)
José-Ángel Hernández-Rivas, Rafael Ríos-Tamayo, Cristina Encinas, Rafael Alonso, Juan-José Lahuerta
The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies. Biomarker research 10 (1) (2022)
Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Ortiol, Laura Rosiñol, María-Jesús Blanchard, José-María Bellón, Miriam Santero, Javier de la Rubia, Ana López de la Guía, Ana Jímenez-Ubieto, Isidro Jarque, Belén Iñigo, Victoria Dourdil, Felipe De Arriba, Clara Cuéllar Pérez-Ávila, Yolanda Gonzalez, Miguel-Teodoro Hernández, Joan Bargay, Miquel Granell, Paula Rodríguez-Otero, Maialen Silvent, Carmen Cabrera, Rafael Rios, Adrian Alegre, Mercedes Gironella, Marta-Sonia Gonzalez, Anna Sureda, Maria Antonia Sampol, Enrique M Ocio, Isabel Krsnik, Antonio García, Aránzazu García-Mateo, Joan-Alfons Soler, Jesús Martín-Sánchez, José-María Arguiñano, Maria-Victoria Mateos-Manteca, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Joaquin Martinez Lopez, null null
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma. Blood cancer journal 12 (4) (2022)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, Ibai Goicoechea, Cristina Perez, Juan-José Garcés, Cirino Botta, María-José Calasanz, Norma C Gutierrez, Maria-Luisa Martin-Ramos, Albert Oriol, Rafael Rios-Tamayo, Miguel-Teodoro Hernandez, Rafael Martinez-Martinez, Joan Bargay, Felipe De Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Adrian Mosquera-Orgueira, Marta-Sonia Gonzalez-Perez, Joaquin Martinez-Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos, Jesus F San-Miguel, Bruno Paiva
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Rafael Rios-Tamayo, Juan José Lahuerta, Juan-José Lahuerta, Joaquin Martinez Lopez, Rafael F Duarte
Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal. Cancers 14 (21) (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Cirino Botta, Catarina Da Silva Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, Maria-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan M Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo M Roccaro, Hartmut Goldschmidt, Herve Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Juan José Lahuerta
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology. Blood advances (2021)
Noemí Puig, Juan A Flores-Montero, Leire Burgos, María-Teresa Cedena, Lourdes Cordón, José-Juan Pérez, Luzalba Sanoja-Flores, Irene Manrique, Paula Rodríguez-Otero, Laura Rosiñol, Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Alberto Orfao, Juan José Lahuerta
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers 13 (19) (2021)
Daniel Alameda, Ibai Goicoechea, Marco Vicari, Elena Arriazu, Alice Nevone, Sara Rodriguez, Marta Lasa, Noemi Puig, Maria Teresa Cedena, Diego Alignani, Sonia Garate, David Lara-Astiaso, Amaia Vilas-Zornoza, Sarai Sarvide, Enrique María Ocio, Ramon Lecumberri, Alfonso Garcia de Coca, Jorge Labrador, Maria-Esther Gonzalez, Luis Palomera, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Albert Ortiol, Isabel Krsnik, Albert Perez-Montaña, Javier de la Rubia, José Enrique de la Puerta, Felipe de Arriba, Vito Michele Fazio, Joaquin Martinez Lopez, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Maria-Dolores Odero, Felipe Prosper, Assaf Weiner, Ido Amit, Mario Nuvolone, Jesús San F Miguel, Juan José Lahuerta
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138 (17) (2021)
Noemi Puig, Miguel-Teodoro T Hernandez Garcia, Laura Rosiñol, Esther González, Felipe de Arriba, Albert Ortiol, Verónica González-Calle, Fernando Escalante, Javier de la Rubia, Mercedes Gironella, Rafael Ríos, Ricarda García-Sánchez, José M Arguiñano, Adrián Alegre, Jesús Martín-Sánchez, Norma C Gutiérrez, María-José Calasanz, María L Martín, María Del Carmen Couto, María Casanova, Mario Arnao, Ernesto Pérez-Persona, Sebastián Garzón, Marta S González, Guillermo Martín-Sánchez, Enrique M Ocio, Morton Coleman, Cristina Encinas, Ana M Vale, Ana I Teruel, María Cortés-Rodríguez, Juan José Lahuerta, M Teresa Cedena, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé, Ruben Niesvizky, Maria-Victoria Mateos-Manteca
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood cancer journal 11 (5) (2021)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Cristina Encinas, Anna Sureda, José Ángel Hernández-Rivas, Ana Lopez de la Guía, Diego Conde, Isabel Krsnik, Elena Prieto, Rosalía Riaza Grau, Mercedes Gironella, María Jesús Blanchard, Nerea Caminos, Carlos Fernández de Larrea, María Alicia Senin, Fernando Escalante, José Enrique de la Puerta, Eugenio Giménez, Pilar Martínez-Barranco, Juan José Mateos, Luis Felipe Casado, Joan Bladé, Juan-José Lahuerta, Javier de la Cruz, Jesús San F Miguel
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood cancer journal 10 (10) (2020)
Alejandro Medina Herrera, Noemi Puig, Juan A Flores-Montero, Cristina Jimenez, María Eugenia Sarasquete, María Garcia-Alvarez, Isabel Prieto-Conde, Carmen Chillon, Miguel Alcoceba, Norma C Gutierrez, Albert Oriol, Laura Rosinol, Joan Bladè, Mercedes Gironella, Miguel T Hernandez, Veronica Gonzalez-Calle, Maria-Teresa Cedena, Juan José Lahuerta, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Alberto Orfao, Marcos Gonzalez, Miriam Santero
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma. Blood cancer journal 10 (10) (2020)
Noemí Puig, Luis-Antonio Corchete, José J Pérez-Morán, Julio Dávila-Valls, Teresa Paíno, Javier de la Rubia, Albert Ortiol, Jesús Martín-Sánchez, Felipe de Arriba, Joan Bladé, María-Jesús Blanchard, Verónica González De La Calle, Miriam Santero, Bruno Paiva, Juan-José Lahuerta, Jesús F San-Miguel, Maria-Victoria Mateos-Manteca, Enrique María Ocio
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers 12 (12) (2020)

Juan-José Lahuerta.css-eqlu8i{font-size:small;padding-left:4px;} (Juan Jose Lahuerta, Juan J Lahuerta, J J Lahuerta, Juan José Lahuerta, Juan-Jose Lahuerta)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan-José Lahuerta (Juan Jose Lahuerta, Juan J Lahuerta, J J Lahuerta, Juan José Lahuerta, Juan-Jose Lahuerta)